Antiviral Compounds: Products

RNA polymerase inhibitor; inhibits replication of a broad range of RNA and DNA viruses, including SARS-CoV-2 and Zika

Antiviral compound library for high throughput screening, target validation, assay development and drug repurposing; contains 240 bioactive compounds (100 μL 10 mM DMSO solutions)

SARS-CoV and SARS-CoV-2 PLpro inhibitor

Binds to SARS-CoV-2 frameshifting element and reduces frameshifting efficiency

Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6

Selective exportin-1 (XPO1/CRM1) inhibitor

Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection

Non-nucleoside reverse transcriptase inhibitor

Potent hepatitis C virus (HCV) NS3 protease inihibitor

Selective exportin 1 (XPO1/CRM1) inhibitor

Glutathione (GSH) precursor; maintains stem cell function in culture.

SARS-CoV-2 main protease fluorescent ligand; TR-FRET acceptor

SARS-CoV-2 Mpro Degrader (PROTAC®)